QQQ $ 429.81 $ 8.79 (2.09 %)
DIA $ 380.88 $ -3.56 (-0.93 %)
SPY $ 507.81 $ 5.55 (1.11 %)
TLT $ 87.78 $ -0.61 (-0.69 %)
GLD $ 215.92 $ 1.27 (0.59 %)
$ 0.8
-- x --
-- x --
-- - --
$ 0.51 - $ 1.10
358
na
2.18M
$ -0.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2023 06-30-2023 10-Q
2 05-15-2023 03-31-2023 10-Q
3 03-09-2023 12-31-2022 10-K
4 11-08-2022 09-30-2022 10-Q
5 08-15-2022 06-30-2022 10-Q
6 05-16-2022 03-31-2022 10-Q
7 03-29-2022 12-31-2021 10-K
8 11-15-2021 09-30-2021 10-Q
9 08-12-2021 06-30-2021 10-Q
10 05-17-2021 03-31-2021 10-Q
11 03-30-2021 12-31-2020 10-K
12 11-16-2020 09-30-2020 10-Q
13 08-13-2020 06-30-2020 10-Q
14 05-14-2020 03-31-2020 10-Q
15 03-12-2020 12-31-2019 10-K
16 11-07-2019 09-30-2019 10-Q
17 08-09-2019 06-30-2019 10-Q
18 05-08-2019 03-31-2019 10-Q
19 03-18-2019 12-31-2018 10-K
20 11-14-2018 09-30-2018 10-Q
21 08-14-2018 06-30-2018 10-Q
22 05-15-2018 03-31-2018 10-Q
23 04-02-2018 12-31-2017 10-K
24 11-14-2017 09-30-2017 10-Q
25 08-14-2017 06-30-2017 10-Q
26 05-15-2017 03-31-2017 10-Q
27 03-31-2017 12-31-2016 10-K
28 11-14-2016 09-30-2016 10-Q
29 08-15-2016 06-30-2016 10-Q
30 05-13-2016 03-31-2016 10-Q
31 03-30-2016 12-31-2015 10-K
32 11-16-2015 09-30-2015 10-Q
33 08-11-2015 06-30-2015 10-Q
34 05-15-2015 03-31-2015 10-Q
35 03-31-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-senestech-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5....

 why-springworks-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approv...

 why-cohbar-cwbr-stock-is-down-nearly-50-today

CohBar Inc (NASDAQ: CWBR) shares are trading lower by 47% to $0.92 Wednesday afternoon.

 why-extreme-networks-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers

 cohbar-says-it-intends-to-commence-process-of-liquidating-and-dissolving-itself-in-accordance-with-its-organizational-documents-and-applicable-law

-SEC 8K Filing

 cohbar-says-on-nov-1-got-termination-notice-from-morphogenesis-effective-nov-1-and-merger-agreement-was-terminated-in-accordance-with-terms

-SEC 8K Filing

 cohbar-says-on-oct-31-board-determined-there-was-not-viable-path-forward-to-consummate-merger-primarily-due-to-oral-guidance-received-from-nasdaq

-SEC 8K Filing

 why-faraday-future-intelligent-electric-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Gainers

 cohbar-q2-eps-149-down-from-090-yoy

CohBar (NASDAQ:CWBR) reported quarterly losses of $(1.49) per share. This is a 65.56 percent decrease over losses of $(0.90) pe...

 cohbar-has-received-a-notice-of-allowance-for-its-us-patent-application-titled-therapeutic-peptides-for-the-treatment-of-metabolic-disease-cancer-liver-disease-and-methods-of-modulating-fatty-acid-metabolism

https://patentcenter.uspto.gov/applications/17717982/ifw/docs

 morphogenesis-and-cohbar-announce-results-from-phase-1b-trial-of-ifx-hu20-a-novel-personalized-cancer-vaccine-in-checkpoint-inhibitor-resistant-advanced-merkel-cell-carcinoma-mcc-and-cutaneous-squamous-cell-carcinoma-cscc

Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel...

 morphogenesis-cohbar-announce-acceptance-of-abstract-for-poster-presentation-at-2023-asco-meeting

Details of the presentation are as follows:Title: Phase 1b trial of IFx-Hu2.0, a novel personalized cancer vaccine, in checkpoi...

 why-americas-car-mart-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION